Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection
Decisions could be made within the remit of human rights, and finally go over the opposition between access to care and donor health protection. As PDMPs have created a kind of international human interdependence, it is our responsibility to place both patients and donors under the umbrella of fundamental human rights, to act not as if a choice has to be made between the two, but in ways that protect them both.
Authors
- Leni von Bonsdorff
- Pierre. Tiberghien
- Jean‐Philippe Plançon
- K. van den Hurk
- Jean‐Baptiste Thibert
- Christian Erikstrup
- Cynthia So‐Osman
- Vincenzo de Angelis
Institutions
- Inserm (FR)
- Aarhus University (DK)
- Société Nationale des Chemins de Fer Français (France) (FR)
- Erasmus MC (NL)
- Aarhus University Hospital (DK)
- Sanquin (NL)
- Université Rennes 2 (FR)
- Association Francaise contre les Myopathies (FR)
- Association Française de Pédiatrie Ambulatoire (FR)
- Bretagne Innovation (France) (FR)
- Université Bretagne Loire (FR)
- Public Health Service of Amsterdam (NL)
- Servizio Sanitario Nazionale (IT)
- Université de Rennes (FR)
- Université de Franche-Comté (FR)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1111/vox.70245
- Primary Topic
- Blood donation and transfusion practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00